...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: New Apabetalone Fabry Disease Publication

Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy

https://pubmed.ncbi.nlm.nih.gov/35417091/

Pharmacol Res Perspect. 2022 Jun;10(3):e00949.

PMID: 35417091 PMCID: PMC9007222 DOI: 10.1002/prp2.949

 

Share
New Message
Please login to post a reply